Esperion Therap(ESPR.US)

Event Tracking

Apr2

Esperion Completes Corstasis Acquisition

21:36

Mar10

Esperion Therapeutics released FY2025 earnings on March 10 Pre-Market (EST), actual revenue USD 403.14 M (forecast USD 402.1 M), actual EPS USD -0.1091 (forecast USD -0.0616)

13:30

Esperion Therapeutics released FY2025 Q4 earnings on March 10 Pre-Market (EST), actual revenue USD 168.45 M (forecast USD 166.12 M), actual EPS USD 0.2172 (forecast USD 0.2716)

13:30

Mar3

Esperion Therapeutics to Release FY2025 Q4 Earnings on March 10, Pre-Market EST; Forecast Revenue USD 165.12 M, EPS USD 0.2742

00:16

Nov25

Piper Sandler Upgrades Esperion Therapeutics to Overweight with $9 Price Target

11:50

Nov21

Esperion Therapeutics and Otsuka launch NEXLETOL® in Japan

13:20